Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL

Classifica tra le azioni #40490
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Prezzo delle azioni
$0.0036163
Ultima sincronizzazione: 2023-10-30
Capitalizzazione di mercato
$118.21K
Variazione (1 giorno)
0.39%
Variazione (1 anno)
3,516.30%
Paese
CA
Scambia Canntab Therapeutics Limited (PILL)

Categoria

Healthcare
Storico del prezzo dell'azione per Canntab Therapeutics Limited (PILL)
Prezzo di chiusura più alto: $0.00 il 2025-11-01

Prezzo di chiusura più basso: $6.44 il 2017-11-01
Storico del prezzo dell'azione di Canntab Therapeutics Limited dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 0.00%
2024 -98.51%
2023 -50.94%
2022 -97.46%
2021 -12.65%
2020 80.79%
2019 -53.66%
2018 -94.67%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.15 21.02%
DE
$41.46 47.41%
JP
$212.49 23.19%
CH
$19.19 -0.09%
IN